The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
NCT01479075 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-06-05
Summary
Insulin has a direct effect on the energy metabolism of the brain under basal conditions and has an effect on the hepatic glucose production, lipid metabolism and the secretion of various hormone. The effect of intranasal insulin on peripheral metabolism in humans supposedly is mediated by the vagus nerve.
The purpose of this study is to determine whether central insulin influences the human peripheral insulin sensitivity of liver and muscle and whether vagus nerve stimulation can mimick this effect.
Conditions
Interventions
- DRUG
-
intransal insulin
4x 40mU intranasal insulin
- DRUG
- DEVICE
-
taVNS
- DEVICE
-
sham stimulation
Sponsors & Collaborators
-
German Diabetes Center
lead OTHER
Principal Investigators
-
Michael Roden, MD, Prof · Germyn Diabetic Center
-
Julia Szendrödi, MD, PhD · German Diabetes Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Vagus Stimulation on Peripheral Glucose Metabolism
NCT03615209 ·Status: COMPLETED ·Phase: NA
-
Effects of Age and Obesity on Brain Insulin Sensitivity
NCT04372849 ·Status: COMPLETED ·Phase: NA
-
Improving Insulin Sensitivity by Non-invasive Brain Stimulation
NCT04420650 ·Status: COMPLETED ·Phase: NA
-
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
NCT02468999 ·Status: COMPLETED ·Phase: NA
-
Relative Contribution of Brain Insulin Action for Postprandial Metabolism
NCT06295640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
NCT01206322 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance
NCT04052399 ·Status: UNKNOWN ·Phase: NA
-
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
NCT06487832 ·Status: RECRUITING ·Phase: NA
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects
NCT02053935 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes
NCT00562133 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans
NCT04461015 ·Status: COMPLETED ·Phase: PHASE3
-
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
NCT00212290 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT03392441 ·Status: COMPLETED ·Phase: NA
-
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
NCT01449019 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Effect of Intranasal Insulin on Cognitive Processes and Appetite
NCT03632681 ·Status: COMPLETED ·Phase: NA
-
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833 ·Status: COMPLETED ·Phase: NA
-
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
NCT05098470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response
NCT01534442 ·Status: UNKNOWN ·Phase: NA
-
Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes
NCT04133922 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Studies of Insulin and Glucagon Action in the Liver
NCT07300982 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Peripheral Metabolic Effects of Ghrelin
NCT00771940 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
NCT03227484 ·Status: COMPLETED ·Phase: PHASE2